↓ Skip to main content

Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria

Overview of attention for article published in Frontiers in oncology, December 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Response Evaluation and Survival Prediction Following PD‐1 Inhibitor in Patients With Advanced Hepatocellular Carcinoma: Comparison of the RECIST 1.1, iRECIST, and mRECIST Criteria
Published in
Frontiers in oncology, December 2021
DOI 10.3389/fonc.2021.764189
Pubmed ID
Authors

Meng Zhou, Chunhui Zhang, Jianhua Nie, Yajuan Sun, Ye Xu, Fangfang Wu, Yuhong Huang, Shun Li, Yuan Wang, Yang Zhou, Tongsen Zheng

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 38%
Student > Bachelor 1 13%
Other 1 13%
Student > Master 1 13%
Unknown 2 25%
Readers by discipline Count As %
Medicine and Dentistry 3 38%
Biochemistry, Genetics and Molecular Biology 1 13%
Immunology and Microbiology 1 13%
Engineering 1 13%
Unknown 2 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 January 2024.
All research outputs
#8,586,912
of 26,181,776 outputs
Outputs from Frontiers in oncology
#3,232
of 22,924 outputs
Outputs of similar age
#182,452
of 528,428 outputs
Outputs of similar age from Frontiers in oncology
#163
of 1,351 outputs
Altmetric has tracked 26,181,776 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 22,924 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 528,428 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 1,351 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.